Staar Surgical Co's ability to collect accounts receivable sequentially worsen to 4.69, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Staar Surgical Co's Accounts Receivable average collection period in the Jul 03 2026 quarter, has increased to 78 days, from 71 days, in the Apr 03 2026 quarter.

If we take a look into Healthcare sector 179 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jul 03 2026 from 1345 to 1676.

What is Receivable Turnover Ratio?
What is Staar Surgical Co Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

STAA Receivables Turnover Ratio	(Jul 03 2026) II. Quarter	(Apr 03 2026) I. Quarter	(Jan 02 2026) IV. Quarter	(Sep 26 2025) III. Quarter	(Jun 27 2025) II. Quarter
Y / Y Receivable Change	185.93 %	103.19 %	-35.73 %	-42.49 %	-63.28 %
Y / Y Revenue Change	111.04 %	119.59 %	18.08 %	6.93 %	-55.23 %
Receivable Turnover Ratio (TTM)	4.69	5.14	5.19	4.34	3.5
STAA's Total Ranking	# 1676	# 1345	# 1729	# 1900	# 1188
Accounts Receivable average collection period days	78	71	70	84	104
Seq. Receivable Change	21.32 %	62.14 %	-16.71 %	74.52 %	-13.79 %
Seq. Revenue Change	0.01 %	61.8 %	-38.98 %	113.75 %	4.06 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 79
Healthcare Sector	# 180
Overall Market	# 1676

Receivable Turnover Ratio Statistics
High	Average	Low
1.45	0.95	0.46
(Jun 29 2018)		(Jun 27 2025)

STAA Company Profile • Back to STAA Efficiency Comparisons • Compare STAA Receivables Turnover Ratio to its Competitors

Financial Statements
Staar Surgical Co's Accounts Receivable	$ 98 Millions	Visit STAA's Balance sheet
Staar Surgical Co's Sales TTM	$ 340 Millions	Visit STAA's Income Statement
Sources of STAA's Revenues		Visit STAA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
STAA's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
STAA's Growth Rates	STAA's Roa	STAA's Inventory Turnover Ratio	STAA's Dividend Comparisons
STAA's Profitability Ratios	STAA's Roi	STAA's Asset Turnover Ratio	STAA's Dividend Growth
STAA's Valuation Ratios	STAA's Roe	STAA's Financial Strength Ratios	STAA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jul 03 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jul 03 2026	Receivable at quarter ending Jul 03 2026
Septerna Inc	9.42	$ 98.882 Millions	$ 10.501 Millions
Biofrontera Inc	9.33	$ 45.956 Millions	$ 4.928 Millions
Enanta Pharmaceuticals Inc	9.29	$ 65.258 Millions	$ 7.027 Millions
The Pennant Group Inc	9.27	$ 1,101.710 Millions	$ 118.798 Millions
Crinetics Pharmaceuticals Inc	9.25	$ 42.156 Millions	$ 4.558 Millions
Neuronetics Inc	9.24	$ 154.594 Millions	$ 16.732 Millions
Myomo Inc	9.24	$ 44.242 Millions	$ 4.790 Millions
Harmony Biosciences Holdings inc	9.22	$ 960.191 Millions	$ 104.164 Millions
Bioaffinity Technologies Inc	9.18	$ 5.901 Millions	$ 0.643 Millions
Pavmed Inc	9.16	$ 0.126 Millions	$ 0.014 Millions
Clene Inc	9.16	$ 0.197 Millions	$ 0.022 Millions
Ardent Health Inc	9.16	$ 6,405.940 Millions	$ 699.363 Millions
Lexicon Pharmaceuticals Inc	9.14	$ 41.469 Millions	$ 4.535 Millions
Novavax inc	9.06	$ 413.796 Millions	$ 45.668 Millions
Nuvation Bio Inc	9.05	$ 169.551 Millions	$ 18.737 Millions
Cue Biopharma Inc	9.04	$ 37.654 Millions	$ 4.165 Millions
Sunshine Biopharma Inc	9.03	$ 35.347 Millions	$ 3.916 Millions
Biocryst Pharmaceuticals Inc	9.00	$ 940.613 Millions	$ 104.543 Millions
Edwards Lifesciences Corporation	8.99	$ 6,512.500 Millions	$ 724.750 Millions
Cannapharmarx Inc	8.86	$ 1.699 Millions	$ 0.192 Millions
Grail Inc	8.85	$ 165.263 Millions	$ 18.670 Millions
Guardant Health Inc	8.84	$ 1,183.105 Millions	$ 133.772 Millions
Zomedica Corp	8.84	$ 35.903 Millions	$ 4.063 Millions
Scientific Industries Inc	8.83	$ 5.728 Millions	$ 0.649 Millions
Sanara Medtech Inc	8.76	$ 110.116 Millions	$ 12.568 Millions
Pacs Group Inc	8.75	$ 5,551.038 Millions	$ 634.735 Millions
Acadia Pharmaceuticals Inc	8.70	$ 1,138.643 Millions	$ 130.825 Millions
Fate Therapeutics Inc	8.64	$ 6.491 Millions	$ 0.751 Millions
Tactile Systems Technology Inc	8.62	$ 350.319 Millions	$ 40.623 Millions
Cg Oncology Inc	8.61	$ 6.228 Millions	$ 0.724 Millions

Date modified: 2026-10-05T11:03:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.